Cargando…

Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia

INTRODUCTION: Treatment failure in acute myeloid leukemia is probably caused by the presence of leukemia initiating cells, also referred to as leukemic stem cells, at diagnosis and their persistence after therapy. Specific identification of leukemia stem cells and their discrimination from normal he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terwijn, Monique, Zeijlemaker, Wendelien, Kelder, Angèle, Rutten, Arjo P., Snel, Alexander N., Scholten, Willemijn J., Pabst, Thomas, Verhoef, Gregor, Löwenberg, Bob, Zweegman, Sonja, Ossenkoppele, Gert J., Schuurhuis, Gerrit J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171508/ https://www.ncbi.nlm.nih.gov/pubmed/25244440 http://dx.doi.org/10.1371/journal.pone.0107587

Ejemplares similares

Normal Hematopoietic Stem Cells within the AML Bone Marrow Have a Distinct and Higher ALDH Activity Level than Co-Existing Leukemic Stem Cells
por: Schuurhuis, Gerrit J., et al.
Publicado: (2013)

Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid Leukemia
por: Zeijlemaker, Wendelien, et al.
Publicado: (2019)

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
por: Cloos, Jacqueline, et al.
Publicado: (2018)

AML/Normal Progenitor Balance Instead of Total Tumor Load (MRD) Accounts for Prognostic Impact of Flowcytometric Residual Disease in AML
por: Hanekamp, Diana, et al.
Publicado: (2021)

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression
por: van Spronsen, Margot F., et al.
Publicado: (2023)

P475: EMERGING LEUKEMIA ASSOCIATED IMMUNOPHENOTYPES (LAIPS) IN BONE MARROW OF ACUTE MYELOID LEUKEMIA PATIENTS AFTER INTENSIVE CHEMOTHERAPY.
por: Lam Ngai, Lok, et al.
Publicado: (2023)

P448: PROGNOSTIC SIGNIFICANCE OF MEASURABLE RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN AUTOLOGOUS STEM CELL APHERESIS PRODUCTS OF PATIENTS WITH AML
por: Tettero, Jesse, et al.
Publicado: (2023)

Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML
por: Tettero, Jesse M., et al.
Publicado: (2023)

Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting
por: Hanekamp, Diana, et al.
Publicado: (2020)

MRD Tailored Therapy in AML: What We Have Learned So Far
por: Ngai, Lok Lam, et al.
Publicado: (2021)

Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?
por: Martiáñez Canales, Tania, et al.
Publicado: (2017)

Prospective validation of the prognostic relevance of CD34(+)CD38(–) AML stem cell frequency in the HOVON-SAKK132 trial
por: Ngai, Lok Lam, et al.
Publicado: (2023)

The Novel Oral BET-CBP/p300 Dual Inhibitor NEO2734 Is Highly Effective in Eradicating Acute Myeloid Leukemia Blasts and Stem/Progenitor Cells
por: van Gils, Noortje, et al.
Publicado: (2021)

Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation
por: van den Ancker, Willemijn, et al.
Publicado: (2010)

CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age
por: van den Heuvel-Eibrink, Marry M., et al.
Publicado: (2007)

P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
por: Hermans, Sjoerd, et al.
Publicado: (2023)

Resistance Prediction in AML: Analysis of 4,601 Patients from MRC/NCRI, HOVON/SAKK, SWOG, and MD Anderson Cancer Center
por: Walter, Roland B., et al.
Publicado: (2014)

Inhibition by Sphingosine of Leukemic Cell Killing by Human Monocytes Activated with Interleukin‐2: A Possible Role of Protein Kinase C
por: Nakabo, Yukiharu, et al.
Publicado: (1998)

The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed
por: Bakunina, Katerina, et al.
Publicado: (2021)

Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics
por: Velten, Lars, et al.
Publicado: (2021)

Promiscuous Binding of Invariant Chain-Derived CLIP Peptide to Distinct HLA-I Molecules Revealed in Leukemic Cells
por: van Luijn, Marvin M., et al.
Publicado: (2012)

Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes
por: van Luijn, Marvin M., et al.
Publicado: (2010)

IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival
por: Verhagen, H JMP, et al.
Publicado: (2014)

Genomic amplification of MYC as double minutes in a patient with APL-like leukemia
por: Poddighe, Pino J, et al.
Publicado: (2014)

Rechten & plichten
por: Scholten, Willemijn
Publicado: (2021)

Rechten & plichten
por: Scholten, Willemijn
Publicado: (2022)

Opinie
por: Scholten, Willemijn
Publicado: (2021)

Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters
por: van Gils, Noortje, et al.
Publicado: (2022)

Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival
por: Tettero, Jesse M., et al.
Publicado: (2023)

Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort
por: Brune, Magdalena M., et al.
Publicado: (2021)

The role of mitochondrial proteases in leukemic cells and leukemic stem cells
por: Mirali, Sara, et al.
Publicado: (2020)

Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities
por: Marchand, Tony, et al.
Publicado: (2021)

P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL
por: Tettero, Jesse, et al.
Publicado: (2023)

Clinical value of new drugs in acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2019)

Acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2018)

Leukemic Ischemia: A Case of Myocardial Infarction Secondary to Leukemic Cardiac Involvement
por: Fursevich, Dzmitry, et al.
Publicado: (2017)

Fluorouracil Selectively Enriches Stem-like Leukemic Cells in a Leukemic Cell Line
por: Zhang, Ling, et al.
Publicado: (2010)

Between demonstration and imagination: essays in the history of science and philosophy presented to John D. North
por: Nauta, Lodi, et al.
Publicado: (1999)

Rosacea Granulomatosis in a Neutropenic Leukemic Patient
por: Lee, Woo Joo, et al.
Publicado: (2022)

Metabolism and the leukemic stem cell
por: Abdel-Wahab, Omar, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_far3dk1d3bc4gh10plncc1ikaf